S100A9 and cancer: The S100A9 protein has been observed in cancers, where it is involved in invasion, migration, and the epithelial–mesenchymal transition (EMT) by promoting matrix metalloproteinase expression through the Wnt/beta-catenin and p38 MAPK-signaling pathways [37].